Brunel partners with Elanco to host Diversity in Life Sciences discussion

This past month Brunel and Elanco - a world leading pharmaceutical company that specializes in developing animal health solutions - partnered together to co-host a panel discussion on diversity and inclusion initiatives in the industry called Moving the Needle on Diversity in Life Sciences. The event, conceived as a time for honest discussion on the importance of and challenges to diversity and inclusion initiatives, was a great success.  More than 100 attendees from across the globe attended the virtual event to learn how they can “move the needle” and create positive change in their own daily lives as well as their organizations and workplaces.

The moderator of the discussion was Brunel’s own Angelina Brathwaite, a Senior Client Partner in Life Sciences from Toronto. Angelina also serves as the Global Leader for Brunel’s Diversity, Inclusion and Belonging committee. Angelina said of hosting the event, “diversity is incredibly important as it fosters innovation and removes barriers against stagnation, suppression and parallel thoughts. Diversity, inclusion and belonging must coexist to create a culture where employees  feel they are empowered, authentic and are supported equally."

Expertise from Around the Globe

The panelists for the discussion were 3 leaders helping to create a more inclusive pharmaceutical industry around the world.